恆指午後跌幅擴至逾150點 騰訊及美團跌近2%
內地4月通脹年率續降溫至0.1%創逾兩年低,低於市場預期升0.3%。期內,PPI按年降3.6%(前值降2.5%),為35個月來最大降幅,也超過預期僅降3.3%。滬指三連跌,現報3,309,跌0.3%。
港股三連跌,恆指繼今早彈近百點至19,854無以為繼掉頭倒跌後,下午降幅擴大,最低見19,598,現報19,608,續跌153點或0.8%,總成交額僅678億元。此外,恆生科指蒸發曾漲2%所有升幅,報3,814,僅升3點。
藍籌股普遍受壓,下周三放榜的權重股騰訊(00700.HK)繼今早高見333.6元無以為繼倒跌後,下午低見323.2元創逾四個月低,現報324.2元,倒跌1.7%。網易(09999.HK)、京東(09618.HK)及美團(03690.HK)也跌逾1%,後者沽壓最大,股價四連跌,最低見126.4元,現報126.6元,續跌1.9%。然而,阿里(09988.HK)及百度(09888.HK)逆升1.6%及1%,報81.5元及115.7元。
國際油價昨晚吐逾1%,「三桶油」跌逾1%--2%,中海油(00883.HK)報12.68元,跌逾2%;中石化(00386.HK)三連跌,最低見5.07,現報5.16元,續跌1.1%。
出口股創科(00669.HK)及申洲(02313.HK)續跌2.7%,分別報80元及67.5元。
地產股以碧桂園(02007.HK)及龍湖(00960.HK)沽壓最大,股價續跌2%及3.6%,報1.93元及19.96元;但長實(01113.HK)逆升0.4%報46.2元。
金融股以工行(01398.HK)及中銀(02388.HK)跌幅較大,股價分別三連跌及兩連跌,現報4.4元及24.55元,續跌逾1%。匯控(00005.HK)今天除息,股價高見59.15元遇壓,現報58.6元,僅微升。
藥明生物(02269.HK)兩連彈兼重越10天線,今天股價逆同業曾漲逾半成高見47.65元,現報46.6元,續升3%。石藥(01093.HK)跌逾2%報7.68元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.